ReviewInternational journal of hematology2018

Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives.

Ken-Ichi MatsuokaPubMed ↗Publisher ↗

No numbers read from the abstract.